AbbVie bets on Anima mRNA modulators to tackle cancer
AbbVie and Anima Biotech have announced a collaboration to discover and develop mRNA biology modulators…
AbbVie and Anima Biotech have announced a collaboration to discover and develop mRNA biology modulators…
Deep Science Ventures (DSV), a London-based venture creator, is teaming up with AbbVie, a global…
Gate Neurosciences has officially launched to develop its next-generation therapeutics addressing synaptic dysfunction in patients…
Formulations of a drug that can help a number of inflammatory diseases including rheumatoid arthritis…
A new drug discovery collaboration has taken place between Japanese Sosei Group Corporation and UK-based…
Exploratory analysis of anti-cancer drug, navitoclax, combined with ruxolitinib - a medication for the treatment…
French pharmaceutical company, Juvisé has just bought worldwide commercial rights to Pylera from US biopharmaceutical…
AbbVie and Genmab have announced a €3.4B collaboration deal that ranks as the second biggest…
The UK biotech Mission Therapeutics has teamed up with AbbVie to develop new drugs to…
This week, Inventiva has received a milestone payment from Boehringer Ingelheim and extended its collaboration with…
Apogenix' partner AbbVie has started the first clinical trial for an immuno-oncology candidate with the…
Galapagos has announced to kick off a Phase I trial with its novel Cystic Fibrosis…